Style | Citing Format |
---|---|
MLA | Mokhtarpour K, et al.. "Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study." Endocrinology# Diabetes and Metabolism, vol. 7, no. 3, 2024, pp. -. |
APA | Mokhtarpour K, Yadegar A, Mohammadi F, Aghayan S, Seyedi S, Rabizadeh S, Esteghamati A, Nakhjavani M (2024). Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study. Endocrinology# Diabetes and Metabolism, 7(3), -. |
Chicago | Mokhtarpour K, Yadegar A, Mohammadi F, Aghayan S, Seyedi S, Rabizadeh S, Esteghamati A, Nakhjavani M. "Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study." Endocrinology# Diabetes and Metabolism 7, no. 3 (2024): -. |
Harvard | Mokhtarpour K et al. (2024) 'Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study', Endocrinology# Diabetes and Metabolism, 7(3), pp. -. |
Vancouver | Mokhtarpour K, Yadegar A, Mohammadi F, Aghayan S, Seyedi S, Rabizadeh S, et al.. Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study. Endocrinology# Diabetes and Metabolism. 2024;7(3):-. |
BibTex | @article{ author = {Mokhtarpour K and Yadegar A and Mohammadi F and Aghayan S and Seyedi S and Rabizadeh S and Esteghamati A and Nakhjavani M}, title = {Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study}, journal = {Endocrinology# Diabetes and Metabolism}, volume = {7}, number = {3}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Mokhtarpour K AU - Yadegar A AU - Mohammadi F AU - Aghayan S AU - Seyedi S AU - Rabizadeh S AU - Esteghamati A AU - Nakhjavani M TI - Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study JO - Endocrinology# Diabetes and Metabolism VL - 7 IS - 3 SP - EP - PY - 2024 ER - |